Knecht, Henrik
,
Reigl, Tomas
Kotrová, Michaela http://orcid.org/0000-0001-5394-1072
Appelt, Franziska
Stewart, Peter
Bystry, Vojtech
Krejci, Adam
Grioni, Andrea
Pal, Karol
Stranska, Kamila
Plevova, Karla
Rijntjes, Jos
Songia, Simona
Svatoň, Michael
Froňková, Eva
Bartram, Jack
Scheijen, Blanca
Herrmann, Dietrich
García-Sanz, Ramón http://orcid.org/0000-0003-4120-2787
Hancock, Jeremy
Moppett, John http://orcid.org/0000-0003-1844-3531
van Dongen, Jacques J. M.
Cazzaniga, Giovanni http://orcid.org/0000-0003-2955-4528
Davi, Frédéric
Groenen, Patricia J. T. A.
Hummel, Michael
Macintyre, Elizabeth A.
Stamatopoulos, Kostas
Trka, Jan
Langerak, Anton W.
Gonzalez, David
Pott, Christiane
Brüggemann, Monika
Darzentas, Nikos
Article History
Received: 15 January 2019
Revised: 23 March 2019
Accepted: 23 April 2019
First Online: 21 June 2019
Compliance with ethical standards
:
: The EuroClonality-NGS Working Group is an independent scientific subdivision of EuroClonality that aims at innovation, standardisation and education in the field of diagnostic clonality analysis. The revenues of the previously obtained patent (PCT/NL2003/000690), which is collectively owned by the EuroClonality Foundation and licensed to InVivoScribe, are exclusively used for EuroClonality activities, such as for covering costs of the Working Group meetings, collective WorkPackages and the EuroClonality Educational Workshops. MB: contract research for Affimed, Amgen, Regeneron, advisory board of Amgen, Incyte, Speaker bureau of Janssen, Pfizer, Roche; AWL: contract research for Roche-Genentech, research support from Gilead, advisory board for AbbVie, speaker for Gilead, Janssen; RG-S: research grants from Gilead, Takeda, Amgen and the Spanish government; and reports consulting fees from Janssen, Takeda, Incyte and BMS; KS: research support from Janssen, Abbvie, Gilead; speaker for Janssen, Abbvie, Gilead; advisory board for Janssen, Abbvie, Gilead; PG: speaker for Gilead. The other authors declare that they have no conflict of interest.